Literature DB >> 9661907

p53 genes mutated in the DNA binding site or at a specific COOH-terminal site exert divergent effects on thyroid cell growth and differentiation.

A Casamassimi1, M G Miano, A Porcellini, G De Vita, F de Nigris, M Zannini, R Di Lauro, T Russo, V E Avvedimento, A Fusco.   

Abstract

Expression of mutated versions of the p53 gene deranged the differentiation program of thyroid cells and resulted in deregulated growth. Specifically, p53 mutants in several residues of the DNA-binding region induced thyrotropin (TSH) -independent growth and inhibition of the expression of thyroid-specific genes. The loss of the differentiated phenotype invariably correlated with the blockage of the expression of the genes coding for the thyroid transcriptional factors PAX-8 and TTF2. Conversely, thyroid cells transfected with a p53 gene mutated at codon 392, located outside the DNA-binding region, stimulated the expression of differentiation genes in the absence of the TSH, and induced TSH-independent growth. cAMP intracellular levels were higher in thyroid cells transfected with the p53 gene mutated at the 392 site than in the untransfected thyroid cells, but lower in the cells transfected with the other mutated p53 genes. Fra-1 and c-jun were induced by p53, resulting in increased AP-1 levels. The results of this study suggest that p53 exerts effects on cAMP transduction pathway in thyroid cells, which are exquisitely sensitive to cAMP.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9661907

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  3 in total

1.  Targeted therapies in thyroid cancer.

Authors:  Jaume Capdevila; Jose Perez-Garcia; Gabriel Obiols; Josep Tabernero
Journal:  Target Oncol       Date:  2009-11-11       Impact factor: 4.493

2.  Accumulation of Fra-1 in ras-transformed cells depends on both transcriptional autoregulation and MEK-dependent posttranslational stabilization.

Authors:  Laura Casalino; Dario De Cesare; Pasquale Verde
Journal:  Mol Cell Biol       Date:  2003-06       Impact factor: 4.272

3.  Do Molecular Profiles of Primary Versus Metastatic Radioiodine Refractory Differentiated Thyroid Cancer Differ?

Authors:  Cristiane J Gomes-Lima; Leila Shobab; Di Wu; Dorina Ylli; Athanasios Bikas; Matthew McCoy; Rebecca Feldman; Wen Lee; Sarika N Rao; Kirk Jensen; Vasily Vasko; Luiz Claudio Castro; Jacqueline Jonklaas; Leonard Wartofsky; Kenneth D Burman
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-25       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.